Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RQI Partners is a joint venture between the American Heart Association and Laerdal Medical, established to improve cardiac arrest survival rates through advanced resuscitation training. The company provides a digital platform that utilizes high-fidelity manikins and real-time feedback to ensure healthcare providers maintain CPR competency. Their "low-dose, high-frequency" training model replaces traditional biennial certification with regular, short practice sessions to prevent skill decay. By focusing on high-quality CPR performance, RQI Partners helps healthcare systems standardize life-saving skills and improve patient outcomes. The organization serves as the primary vehicle for delivering the American Heart Association's digital resuscitation programs globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RQI Partners.